Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | EXPGY | NMR |
|---|---|---|
| Price | $32.52 | $9.75 |
| Change today | ▲ 0.22% | ▲ 0.21% |
| Market cap | $28.49B | $28.50B |
| Return, 3 months | -9.7% | +3.5% |
| Return, year to date | -27.0% | +18.4% |
| Return, 1 year | -30.8% | +35.7% |
| P/E (TTM) | 20.0 | 11.6 |
| P/B | 5.3 | 1.2 |
| P/E percentile vs own 5y | – | 45th |
| Dividend yield | 2.13% | 3.15% |
| Revenue growth (YoY, latest qtr) | – | +28.0% |
| Net profit growth (YoY) | – | +45.3% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | 20.4% |
| Return on equity | – | 11.0% |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 26 | 41 |
| 30-day volatility | 28.6% | 23.8% |
| Max drawdown, 1 year | -35.9% | -22.4% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
